<p>The Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium is an international effort to discover risk loci for prostate cancer. The following de novo genotyping was performed. The OMNI  2.5M genotyping was conducted for 977 prostate cancer cases from UKGPCS. The Exome SNP array genotyping was conducted for 4741 subjects from UKGPCS.</p>

ELLIPSE Prostate Cancer Genotyping

Prostatic Neoplasms study with SNP Genotypes (Array) data on dbGaP (12,947 participants)